Type
1.
INNES. Leprosy in Uganda: a survey in the Kigezi District. East Africa medical journal. 1950;27(7):278-83.
Type
1.
Wheate. An intensive leprosy survey in Teso District, Uganda. East African medical journal. 1950;27(7):274-7.
Type
1.
Verma, Singh, Prakash, Bhatia, S. K. Coexistence of leprosy and pulmonary tuberculosis: An uncommon entity. Medical Journal of Dr D Y Patil University [Internet]. 2015;8(5):675-7. Available from: http://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2015;volume=8;issue=5;spage=675;epage=677;aulast=Verma
Type
1.
Lanza FM Universidade Federal de São João del-Rei, Brasil, Vieira NF, Oliveira MMC, Lana FCF. [Instrument for evaluating the actions of leprosy control in Primary Care]. Revista Brasileira de Enfermagem [Internet]. 2014;67(3):339-46. Available from: http://www.scielo.br/pdf/reben/v67n3/0034-7167-reben-67-03-0339.pdf
Type
1.
Cobat A, Abel L, Alcaïs A, Schurr E. A General Efficient and Flexible Approach for Genome-Wide Association Analyses of Imputed Genotypes in Family-Based Designs. Genetic Epidemiology. 2014;
Type
1.
Tsukamoto Y, Maeda Y, Makino M. Evaluation of major membrane protein-I as a serodiagnostic tool of pauci-bacillary leprosy. Diagnostic Microbiology Infectious Disease. 2014;
Type
1.
Khanna N, Singh M, Rasool S, Ammini A, Bhatla N, Garg V, et al. Menstrual irregularities, fertility status, and ovarian function in female patients with leprosy in India. International Journal of Dermatology. 2014;
Type
1.
Freitas R, Duarte E, Garcia L. Leprosy in Brazil and its association with characteristics of municipalities: ecological study, 2009-2011. Tropical Medicine & International Health. 2014;
Type
1.
Leiker DL. Studies on the lepromin test. III. Influence of tuberculosis contact and other factors on the size of the lepromin reaction. International journal of leprosy & other Mycobactial diseases [Internet]. 1961;29:488-95. Available from: http://ila.ilsl.br/pdfs/v29n4a06.pdf
Type
1.
Meneses GC, Libório AB, Daher EF, Silva GB, Costa MF, Pontes MA, et al. Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage. BMC infectious diseases [Internet]. 2014;14(1):451. Available from: http://www.biomedcentral.com/content/pdf/1471-2334-14-451.pdf